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New selective and sensitive spectrophotometric and spectroﬂuorometric methods have been developed and validated for the
determination of amantadine hydrochloride (AMD) in capsules and plasma. The methods were based on the condensation
of AMD with 1,2-naphthoquinone-4-sulphonate (NQS) in an alkaline medium to form an orange-colored product. The
spectrophotometric method involved the measurement of the colored product at 460 nm. The spectroﬂuorometric method
involved the reduction of the product with potassium borohydride, and the subsequent measurement of the formed ﬂuorescent
reduced AMD-NQS product at 382 nm after excitation at 293 nm. The variables that aﬀected the reaction were carefully
studied and optimized. Under the optimum conditions, linear relationships with good correlation coeﬃcients (0.9972–0.9974)
and low LOD (1.39 and 0.013μgmL
−1) were obtained in the ranges of 5–80 and 0.05–10 μgmL
−1 for the spectrophotometric
and spectroﬂuorometric methods, respectively. The precisions of the methods were satisfactory; RSD ≤ 2.04%. Both methods
were successfully applied to the determination of AMD in capsules. As its higher sensitivity, the spectroﬂuorometric method was
applied to the determination of AMD in plasma; the recovery was 96.3–101.2 ± 0.57–4.2%. The results obtained by the proposed
methods were comparable with those obtained by the oﬃcial method
Copyright © 2009 Ashraf M. Mahmoud et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Amantadine hydrochloride (AMD), Scheme 1, is an antiviral
agent used against infection with inﬂuenza type A virus and
to ameliorate symptoms when administered during the early
stages of infection as well as in the management of herpes
zoster [1]. It has mild anti-Parkinsonism activity and thus it
has been used in the management of Parkinsonism, mainly
in the early disease stage and when the symptoms are mild.
AMD is usually given by mouth as the hydrochloride salt [2].
Spectrophotometry and spectroﬂuorometry are consid-
ered as the most convenient analytical techniques in phar-
maceutical analysis because of their inherent simplicity and
availability in most quality control and clinical laboratories
[3–9]. However, AMD does not possess any chromophore or
ﬂuorophore in its molecule, which are the essential require-
ments for the direct analysis by either spectrophotometric
or spectroﬂuorometric techniques. Therefore, derivatization
of AMD was necessary for its determination by either of
the two techniques. For spectrophotometric determination
of AMD, it has been derivatized with diﬀerent reagents. The
involved derivatization reactions that have been published
prior to 1983 have been reviewed by Kirschbaum [10]. The
derivatizing reagents used thereafter included iodine [11],
acetaldehyde/chloranil [11], α,α-diphenyl-β-picrylhydrazyl
[12], bromocresol green [13], tetracyanoethylene [14],
iron(III) [15], and cyclodextrin [16]. Few spectroﬂuoromet-
ric methods have been reported for the analysis of AMD.
These methods were based on its oxidation with cerium(IV)
[7]orits derivatization with2,3-diphenylquinolizinium bro-
mide [17], ﬂuorescamine [18], and 9-isothiocynatoacridine
[19]. As well, many derivatization techniques coupled with
chromatographyhavebeenestablishedforthedetermination
of AMD in the dosage forms and biological matrices: TLC2 International Journal of Analytical Chemistry
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[20], HPLC [21–23], GC [24], and capillary electrophoresis
[25]. 1,2-Naphthoquinone-4-sulphonate (NQS) has been
used for the determination of many compounds [26–28].
The reaction between NQS and AMD has not been investi-
gatedyet.Therefore,thepresentstudywasdevotedtoexplore
NQS as a derivatizing reagent in the development of selective
and sensitive spectrophotometric and spectroﬂuorometric
methods for the determination of AMD in capsules and
plasma.
2. Experimental
2.1. Apparatus. UV-1601 PC (Shimadzu, Kyoto, Japan)
ultraviolet-visible spectrophotometer with matched 1cm
quartz cells was used for all spectrophotometric measure-
ments. Spectroﬂuorimeter, Kontron SFM 25 equipped with a
150W xenon high-pressure lamp wasused formeasuring the
ﬂuorescenceintensity.MLWtypethermostaticallycontrolled
water bath (Memmert GmbH, Co. Schwa bach, Germany).
Biofuge Pico centrifuge (Heraeus Instruments, Germany).
2.2. Chemicals and Materials. Amantadine hydrochloride
(AMD; Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many) was obtained and used as received, its purity was
100.02 ± 1.25%. 1,2-naphthoquinone-4-sulphonate; (NQS;
El-Nasr Pharmaceutical Chemical Co., Abo-Zaabal, Egypt).
Potassium borohydride (Sigma-Aldrich Chemie GmbH,
Steinheim, Germany). Adamine capsules (Rameda Co. for
Pharmaceutical Industries & Diagnostic Reagents, Cairo,
Egypt) are labeled to contain 100mg of AMD per capsule.
Human plasma samples were collected from normal healthy
volunteer at King Khaled University Hospital (Riyadh,
Kingdom of Saudi Arabia), and they were stored at −20
◦C
until analysis. All solvents and materials used throughout
this study were of analytical grade. Double distilled water
was obtained through WSC-85 water puriﬁcation system
(Hamilton Laboratory Glass Ltd., Ky, USA), and used
throughout the work.
2.3. Preparation of Standard and Sample Solutions
2.3.1. Amantadine Hydrochloride (AMD) Standard Solutions.
An accurately weighed amount (100mg) of AMD was quan-
titatively transferred into a 50mL calibrated ﬂask, dissolved
in 30mL distilled water, completed to volume with the same
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Figure 1: Absorption, excitation, and emission spectra on the
reaction products of AMD with NQS (0.06%, w/v). (a) Absorption
spectrum of the reaction product of AMD (65μgmL
−1) with
NQS after extraction with chloroform. (b) (1) Excitation and (2)
emission spectra of the reduced reaction product. RFI is the relative
ﬂuorescence intensity.
s o l v e n tt oo b t a i nas t o c ks o l u t i o no f2m gm L
−1.T h i ss t o c k
solution was further diluted with water to obtain working
solutions in the ranges of 50–800 and 0.5–100μgm L
−1 for
the spectrophotometric and spectroﬂuorometric methods,
respectively.
2.3.2. 1,2-Naphthoquinone-4-sulphonate (NQS) Derivatizing
Reagent. Accurately weighed amount of NQS (150mg) was
transferred into a 25mL calibrated ﬂask, dissolved in 5mL
distilled water, completed to volume with water to obtain a
solution of 0.6% (w/v). The solution was freshly prepared
and protected from light during use.
2.3.3. Capsules Sample Solution. Twenty capsules were care-
fully evacuated; their contents were weighed and ﬁnely
powdered. An accurately weighed quantity of the capsule
contents equivalent to 100mg of AMD was transferred into
a 100mL calibrated ﬂask, and dissolved in about 40mLInternational Journal of Analytical Chemistry 3
of distilled water. The contents of the ﬂask were swirled,
sonicated for 5 minutes, and then completed to volume with
water. The contents were mixed well and ﬁltered rejecting
the ﬁrst portion of the ﬁltrate. The prepared solution was
diluted quantitatively with distilled water to obtain a suitable
concentration for the analysis.
2.3.4. Spiked Plasma Samples. Aliquots of 1.0mL of plasma
were spiked with diﬀerent concentration levels of AMD. The
spiked plasma samples were treated with 0.1mL of 70%
perchloric acid and vortexed for 1 minute. The samples were
centrifuged for 20 minutes at 13000rpm. The supernatants
were transferred into test tubes and neutralized with 1M
NaOH solution.
2.4. General Recommended Procedure
2.4.1. Spectrophotometric Method. One milliliter of the stan-
dard or sample solution (50–800 μgmL
−1) was transferred
into a test tube. One milliliter of 0.01M NaOH and 1ml
of NQS reagent (0.6%, w/v) were added. The contents of
the tubes were heated in a water bath at 80 ± 5◦Cf o r4 5
minutes and then cooled in ice water for 2 minutes. The
contents of the test tubes were transferred quantitatively into
a separating funnel containing anhydrous sodium sulphate
and extracted with two portions (5mL) of chloroform.
The combined chloroformic extracts were transferred into
10mL calibrated ﬂasks and the solutions were completed to
volume with chloroform if necessary. The absorbances of the
resulting solutions were measured at 460nm against reagent
blanks treated similarly.
2.4.2. Spectroﬂuorometric Method. One milliliter of the stan-
dard or sample solution (0.5–100μgmL
−1) was transferred
into a test tube. One milliliter of 0.01M NaOH and 1mL
of NQS reagent (0.6%, w/v) were added. The contents of
the test tubes were heated in a water bath at 80 ± 5◦Cf o r
45 minutes and then cooled in ice water for 2 minutes.
The contents of the test tubes were transferred quantitatively
into a separating funnel and extracted with two portions
(5mL) of chloroform. The combined chloroformic extracts
were evaporated under stream of air and the residues
were reconstituted in 2mL of methanol and quantitatively
transferred into 10mL calibrated ﬂask. A one milliliter of
KBH4 solution (0.03%, w/v in methanol) was added and
the reaction was allowed to proceed for 5 minutes at room
temperature (25 ± 5◦C). The solution was diluted to volume
with 0.025M ethanolic HCl and the ﬂuorescence intensity
of the resulting solution was measured at 382nm after
excitation at 293nm against reagent blanks treated similarly.
2.5. Determination of the Molar Ratio of the Reaction. The
J o b ’ sm e t h o do fc o n t i n u o u sv a r i a t i o n[ 29]w a se m p l o y e d .
Master equimolar (2.5×10
−2 M) aqueous solutions of AMD
and NQS were prepared. Series of 5mL portions of the
master solutions of AMD and NQS were made up com-
prisingdiﬀerentcomplementaryproportions(0:10,1:9,...,
9:1, 10:0, inclusive) in test tubes. One milliliter of 0.01M
NaOH was added to each tube, and the tubes were further
manipulated as described under the general recommended
procedure for the spectrophotometric method.
3. Results and Discussion
3.1. Strategy for Assays Development, Involved Reaction,
and Spectral Characteristics. Because of the absence of any
chromophoric group in the AMD molecule, it has no
absorption in the ultraviolet-visible region above 200nm,
and it has no native ﬂuorescence as well. Therefore, direct
spectrophotometricandﬂuorimetricdeterminationofAMD
were not possible. Therefore, derivatization of AMD was
attempted in the present study for the development of
both spectrophotometric and spectroﬂuorometric methods
for its determination. NQS has been used as chromogenic
and ﬂuorogenic reagent for primary and secondary amines
[26–28, 30], however, its reaction with AMD has not been
investigated yet. Therefore, the present study was devoted to
explore NQS as a derivatizing reagent in the development
of spectrophotometric and spectroﬂuorometric methods for
the determination of AMD in capsules and plasma. Our pre-
liminary experiments in investigating the reaction between
AMD and NQS revealed that NQS-AMD product is orange
colored exhibiting a maximum absorption at 460 nm and it
is insoluble in water, but soluble in organic solvents. Since
the present work was directed to involve plasma samples, the
interference of endogenous amines was a major concern. It
is well known that NQS reacts with the endogenous amines
(e.g., amino acids) and yields water-soluble products [30].
For this reason, an extraction step was necessary for the
development of selective methods for the determination of
AMD in the presence of the endogenous amines. As well, the
reduced AMD-NQS derivative was found to be ﬂuorescent
and exhibited one emission maximum at 382nm and three
excitation maxima at 293, 325, and 344nm. The highest
ﬂuorescence intensity was obtained after excitation 293nm,
thus the excitation in the present study was performed
at this wavelength. Scheme 2 shows the reaction pathway
between AMD and NQS, and Figure 1 shows the absorption,
excitation, and emission spectra of the reaction product.
The following sections describe the optimization of the
assay variables and validation for the performance of both
spectrophotometric and spectroﬂuorometric methods.
3.2. Method Development
3.2.1. Optimization of Derivatization Reaction and Spec-
trophotometric Procedure. The factors aﬀecting the deriva-
tization reaction (the concentrations of NQS and NaOH,
reaction time, temperature, diluting solvent, and the extract-
ing solvent) were investigated by altering each variable in a
turn while keeping the others constant. The studying of NQS
concentrations revealed that the reaction was dependent on
NQS reagent (Figure 2). The highest absorption intensity
was attained when the concentration of NQS was 0.06–
0.075% (w/v) in the ﬁnal solution; further experiments were
carriedoutatNQSconcentrationof0.06%(w/v).Theresults4 International Journal of Analytical Chemistry
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Scheme 2: Scheme for the reaction pathway of amantadine hydrochloride (AMD) with 1,2-naphthoquinone-4-sulphonate (NQS).
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Figure 2: Eﬀe c to fN a O H( ◦) and NQS(•) concentrations on the
reaction of AMD (45μgmL
−1) with NQS.
of investigating the eﬀect of NaOH concentration on the
reaction revealed that the optimum NaOH concentration
was 0.01M (Figure 2). The eﬀect of temperature on the
derivatization reaction was studied by carrying out the reac-
tionatdiﬀerenttemperatures(25–100
◦C)andthemaximum
readings were obtained at 70–100
◦C( Figure 3). For more
precise readings, further experiments were carried out at
80 ± 5◦C. The eﬀect of heating time on the formation
of the reaction product was investigated by carrying out
the reaction at diﬀerent times. The maximum absorbance
intensity was attained after 40 minutes, and longer reaction
time did not aﬀect the absorbance intensity (Figure 3). For
more precise results, further experiments were carried out at
45 minutes.
It was found that the colored AMD-NQS product is
insoluble in the aqueous reaction medium. For measure-
ments, the reaction product might be either dissolved in
a miscible organic solvent of lower polarity than water
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Figure 3: Eﬀect of heating temperature (◦) and time (•)o nt h e
reaction of AMD (45 μgmL
−1) with NQS.
or extracted with an immiscible extractive solvent. Diﬀer-
ent solvents were tested for dilution; methanol, ethanol,
acetonitrile, dimethylsulphoxide, isopropanol, 1,4-dioxane,
and acetone. The highest readings were obtained when
dioxane was used for dilution (data not shown). As well,
diﬀerent nonmiscible solvents were tested for the extraction
of the AMD-NQS product: carbon tetrachloride, chloro-
form, dichloromethane, ethyl acetate, toluene, and benzene.
The highest readings were obtained when chloroform was
used for extraction (Table 1). The results revealed that the
extractive procedure is more sensitive (1.5 fold) than the
nonextractive procedure. This was attributed to the eﬀective
decrease in the blank readings and consequently enhanced
the sensitivity of the assay.
3.2.2. Optimization of Spectroﬂuorometric Procedure. For
developing the spectroﬂuorometric procedure, a reduction
step for AMD-NQS product was necessary. However, theInternational Journal of Analytical Chemistry 5
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Figure 5: Eﬀect of pH on the ﬂuorescence intensity of the reduced
reaction product of AMD-NQS. RFI is the relative ﬂuorescence
intensity.
reduced NQS reagent itself is also ﬂuorescent and it had
the same excitation and emission maxima of the AMD-
NQS product, therefore, a selective extraction step for
the AMD-NQS product from the remaining NQS reagent
was necessary before carrying out the reduction step.
Furthermore, the extraction step is essential to provide
the required selectivity for analyzing the plasma samples
as the NQS products with endogenous amines were water
soluble. Based on the reported eﬃciency [30], potassium
borohydride as a reducing reagent was selected for NQS-
derivatives. In order to investigate the eﬀect of potassium
borohydride concentration on the reduction, the reaction
wasperformedusingvaryingconcentrations(0.0005–0.01%,
w/v). The highest ﬂuorescence intensity was obtained when
the concentration was 0.003% in the ﬁnal solution (1mL
of 0.03%, w/v). Concentrations more than 0.003% did not
aﬀect the ﬂuorescence intensity (Figure 4). The eﬀect of pH
on the ﬂuorescence intensity was also studied and the results
showed that the highest ﬂuorescence intensity was obtained
at pH 2.0 (Figure 5). This pH could be attained by diluting
the reaction mixture with 0.025M ethanolic HCl solution.
3.3. Stoichiometry of Derivatization Reaction. Under the
optimum conditions, the stoichiometry of the reaction
between AMD and NQS was investigated by Job’s method
[29] and was found to be 1:1 because AMD molecule
contains only one center (primary amino group) available
for this condensation reaction. Based on this ratio, the
reaction pathway was postulated to be proceeded as shown
in Scheme 2.
3.4. Method Validation
3.4.1. Linearity, Limits of Detection and Quantitation. In
the proposed methods, linear plots (n = 6) with good
correlation coeﬃcients (0.9974 and 0.9972) were obtained
in the concentration ranges of 5–80μgmL
−1 for and 0.05–
10μgmL
−1 for the spectrophotometric and the spectroﬂu-
orometric methods, respectively (Table 2). The limits of
detection (LOD) and quantitation (LOQ) were determined
[31] using the formula LOD or LOQ = κSDa/b, where
κ = 3.3 for LOD and 10 for LOQ, SDa is the standard
deviation of the intercept, and b is the slope. The LOD values
were 1.39 and 0.013μgmL
−1 for the spectrophotometric and
spectroﬂuorometric methods, respectively (Table 2).
3.4.2. Precision and Accuracy. The precision of the proposed
methods was determined by replicate analysis of ﬁve separate
sample solutions at three concentration levels of AMD. The
relativestandarddeviations(RSDs)were0.83–0.96and0.46–
1.01% for the spectrophotometric and spectroﬂuorometric
methods, respectively (Table 3), indicating the good repro-
ducibility of the proposed methods. Furthermore, the inter-
and intra-assay precisions of the proposed spectroﬂuoro-
metric method were determined from the recovery studies
of spiked human plasma samples. The RSD values of the
recovery were 0.57–2.04 and 0.72–4.20% for the intra-
and inter-assay determinations, respectively (Table 4). The
accuracy of the proposed methods was evaluated by standard
addition method. The obtained recovery values were 98.8–
100.2 ± 1.04–1.54% indicating the high accuracy of the
proposed methods. Moreover, the accuracy of the proposed
spectroﬂuorometric method was evaluated by the recovery
studies of spiked human plasma samples. The obtained
recoveryvalueswere96.3–101.2±0.57–4.2%(Table 4).These
recovery results of the spiked human plasma indicate the
suitability of the proposed spectroﬂuorometric method for
the analysis of AMD in human plasma.
3.4.3. Interference Studies. The results of the interferences
study showed that no interferences were found from any
of the excipients studied; lactose, sucrose, starch, talc, gum
acacia, glucose, and magnesium stearate; the recovery of
AMD was 98.15–100.72%. This indicated the absence of6 International Journal of Analytical Chemistry
Table 1: Eﬀect of diluting and extracting solvents on the intensity of the reaction product of AMD with NQS (0.06%, w/v). Values for all
solvents are mean of three determinations; the RSDs for the readings were <3.
Spectrophotometric method Spectroﬂuorometric method
Extracting solvent Absorbance Diluting solvent Fluorescence intensity
Carbon tetrachloride 0.487 Methanol 65.66
Chloroform 0.718 Ethanol 78.38
Dichloromethane 0.616 Isopropanol 63.02
Ethyl-acetate 0.362 Acetone 2.00
Toluene 0.267 Acetonitrile 16.18
Benzene 0.239 Dimethylformamide 3.94
1,4-Dioxane 76.11
Table 2: Quantitative parameters and statistical data for determination of amantadine hydrochloride by the proposed spectrophotometric
and spectroﬂuorometric methods.
Parameter Spectrophotometric method Spectroﬂuorometric method
Range (μgm L
−1) 5.00–80.0 0.05–10.0
Intercept (a) 0.0759 ±0.0041 −2.457 ±0.332
Slope (b) 0.00974 ±0.00035 81.969 ±2.154
Correlation coeﬃcient (r) 0.9974 0.9972
ε ×103 (L mol
−1 cm−1) 2.058 —
LOD (μgm L
−1) 1.39 0.013
LOQ (μgm L
−1) 4.21 0.041
Table 3 :T h ep r e c i s i o no ft h ep r o p o s e dm e t h o d sa tt h r e ec o n c e n -
tration levels of AMD.
Method Nominal concentration (μgm L
−1)R S D %
(a)
Spectrophotometric
8.0 0.96
40.0 0.83
60.0 0.87
Spectroﬂuorometric
0.1 1.01
4.0 0.58
8.0 0.46
(a)Values are mean of ﬁve determinations.
Table 4: Recovery studies for the proposed spectroﬂuorometric
method for the determination of AMD in spiked human plasma.
Spiked concentration (μgm L
−1) Recovery (% ± RSD)
(a)
Intra-assay Inter-assay
0.05 98.2 ±2.04 96.3 ±4.20
0.10 99.3 ±1.01 101.1 ±2.0
0.20 100.5 ±0.99 99.1 ±1.50
0.40 100.9 ±0.74 98.5 ±1.52
0.80 100.1 ±0.75 101.2 ±1.44
1.60 98.6 ±0.82 100.3 ±1.12
3.20 98.9 ±0.57 99.7 ±0.72
(a)Values are mean of three and ﬁve determinations for intra- and inter-
assay, respectively.
interferences from these excipients. Moreover, the interfer-
ences from the amino acids with the assay procedures were
also studied using glycine as an example for the amino
acids. The results of this study revealed that the amino acids
Table 5: Analysis of AMD in capsules by the proposed and oﬃcial
methods.
Method Recovery (% ±SD)
(a) t-value
(b) F-value
(b)
Spectrophotometric 98.70 ±1.79 0.42 1.64
Spectroﬂuorometric 98.91 ±1.91 0.19 1.85
Oﬃcial HPLC
(c) 99.13 ±1.41 — —
(a)Values are mean of ﬁve determinations.
(b)Theoretical values for t and F at 95% conﬁdence limit and n = 5w e r e
2.31 and 6.39, respectively.
(c)Reference [32].
could interfere with the spectrophotometric procedures.
However, there is no any interference coming from the
amino acids after an extraction step for the derivatized AMD
product because the derivatized amino acids products are
water soluble. Therefore, the extraction step increased both
the sensitivity and selectivity by removing the interferences
caused by both amino acids and proteins in the plasma
samples.
3.4.4. Robustness and Ruggedness. Robustness was examined
by evaluating the inﬂuence of small variation of method
variables, including concentration of analytical reagents
and reaction time on the performance of the proposed
methods. In these experiments, one parameter was changed
whereas the others were kept unchanged, and the recovery
percentage was calculated each time. It was found that small
variation of method variables did not signiﬁcantly aﬀect the
procedures. This provided an indication for the reliability
of the proposed method during its routine application for
the analysis of AMD. Ruggedness was also tested by applyingInternational Journal of Analytical Chemistry 7
the proposed methods to the assay of AMD using the same
operationalconditionsbutusingtwodiﬀerentinstrumentsat
two diﬀerent laboratories and diﬀerent elapsed time. Results
obtained from lab-to-lab and day-to-day variations were
found to be reproducible, the full range of recovery values
was 98.4–101.3% and the RSD was 0.73 and 1.06% for
the spectrophotometric and spectroﬂuorometric methods,
respectively.
3.5. Application of the Proposed Method to Analysis of AMD in
Capsules. Itisevidentfromtheabove-mentionedresultsthat
the proposed methods gave satisfactory results with AMD in
bulk. Thus, its capsules were subjected to the analysis of their
contents from the active ingredient by the proposed methods
and the oﬃcial (nonaqueous titration) method [32]. The
capsulecontents,aspercentage,were98.70±1.79and98.91±
1.93% for the spectrophotometric and spectroﬂuorometric
methods,respectively(Table 5).Theseresultswerecompared
with those obtained from the oﬃcial method by statistical
analysis with respect to the accuracy (t-test) and precision
(F-test). No signiﬁcant diﬀerences were found between the
calculated and theoretical values of t-a n dF-tests at 95%
conﬁdence limit proving similar accuracy and precision in
the analysis of AMD in its dosage form.
4. Conclusions
The present study described the use of NQS reagent for
the development of selective, sensitive, and accurate spec-
trophotometric and spectroﬂuorometric methods for the
determination of AMD in bulk, capsules, and plasma. The
described methods are superior to the previously reported
spectrophotometric or spectroﬂuorometric methods for
analysis of AMD in terms of their selectivity and sensitivity.
The linear ranges of the proposed spectrophotometric and
spectroﬂuorometric methods were 5–80 and 0.05–10μg/mL,
respectively, which are much less than some reported
methods100–1300, 15–90, 25–75, 94–940μg/mL[11,14,15]
which were based on either the nonselective oxidation or
charge-transfer complex formation of AMD base. Although
the sensitivity of the proposed spectroﬂuorimetric method
is comparable to that described by Darwish et al. [7], which
was based on the nonselective oxidation of AMD with cerric
sulphate, however, our proposed methods are more selective.
Also, The proposed methods involved spectrophotometric
and spectroﬂuorometric measurements with comparable
analytical performance devoid from any potential interfer-
ence. This gives the advantage of ﬂexibility in performing
the analysis on any available instrument. Furthermore, all
the analytical reagents are inexpensive, have excellent shelf
life, and are available in any analytical laboratory. Therefore,
these methods can be recommended for the routine analysis
of AMD in quality control and clinical laboratories.
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